製品名
Human Decorin ELISA Kit, for serum, plasma, cell culture supernatant and urine
species reactivity
human
packaging
kit of 96 wells (12 strips x 8 wells)
technique(s)
ELISA: suitable
capture ELISA: suitable
input
sample type cell culture supernatant(s)
sample type urine
sample type serum
sample type plasma
assay range
inter-assay cv: <12%
intra-assay cv: <10%
sensitivity: 1.5 pg/mL
standard curve range: 0.96-700 pg/mL
detection method
colorimetric
shipped in
wet ice
storage temp.
−20°C
Gene Information
human ... DCN(1634)
Application
For research use only. Not for use in diagnostic procedures.
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)
Please refer to the attached General ELISA KIT Procedure (sandwich, competitive & Indirect ELISA)
Human Decorin ELISA Kit has been used in sandwich enzyme-linked immunosorbent assay (ELISA) of mice serum. It has also been used in the ELISA of plasma samples and cerebrospinal fluid (CSF) of glioma patients.
Biochem/physiol Actions
Decorin is involved in a wide variety of biological processes including cell differentiation, growth and muscle development. It also takes part in wound healing, angiogenesis and regulates autophagy and inflammation. Decorin interacts with matrix proteins and inhibits tumor migration and growth.
General description
Decorin comprises dermatan sulfate or a chondroitin sulfate chain. It belongs to the small leucine-rich proteoglycan (SLRP) gene family and is expressed majorly in the myofibroblasts and fibroblasts.
The Human Decorin ELISA (Enzyme-Linked Immunosorbent Assay) kit is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of human Decorin in serum, plasma, cell culture supernatants and urine.
Immunogen
Recombinant Human Decorin
Other Notes
A sample Certificate of Analysis is available for this product.
Please type the word sample in the text box provided for lot number.
Please type the word sample in the text box provided for lot number.
signalword
Warning
hcodes
pcodes
Hazard Classifications
Met. Corr. 1
保管分類
8A - Combustible corrosive hazardous materials
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Please refer to KIT Component information
pdsc
Please refer to KIT Component information
prtr
Please refer to KIT Component information
fsl
Please refer to KIT Component information
ishl_indicated
Please refer to KIT Component information
ishl_notified
Please refer to KIT Component information
cart
キットコンポーネントの情報を参照してください
jan
Mohammad F Siddiqui et al.
American journal of obstetrics and gynecology, 215(3), 361-361 (2016-03-24)
Decorin, a leucine-rich proteoglycan that is produced by decidual cells, limits invasion and endovascular differentiation of extravillous trophoblast cells during early placentation by binding to multiple tyrosine kinase receptors, in particular, vascular endothelial growth factor receptor-2. Because many studies have
Andrea Reszegi et al.
Frontiers in oncology, 10, 645-645 (2020-06-02)
Hepatocellular carcinoma (HCC) represents one of the most frequent type of primary liver cancers. Decorin, a small leucine-rich proteoglycan of the extracellular matrix, represents a powerful tumor cell growth and migration inhibitor by hindering receptor tyrosine kinases and inducing p21WAF1/CIP1.
Dong-Ming Kuang et al.
The Journal of clinical investigation, 124(10), 4657-4667 (2014-09-23)
Classical IL-22-producing T helper cells (Th22 cells) mediate inflammatory responses independently of IFN-γ and IL-17; however, nonclassical Th22 cells have been recently identified and coexpress IFN-γ and/or IL-17 along with IL-22. Little is known about how classical and nonclassical Th22
Ting Yao et al.
FEBS open bio, 6(7), 707-719 (2016-07-12)
Decorin (DCN) is a major member of the small leucine-rich proteoglycan (SLRP) family that is critically involved in tumorigenesis and the development of metastasis of cancers, including glioma. Overexpression of DCN was indicated to suppress glioma cell growth. However, the
Sergio Occhipinti et al.
Clinical cancer research : an official journal of the American Association for Cancer Research, 20(11), 2910-2921 (2014-03-29)
Despite the great success of HER2 vaccine strategies in animal models, effective clinical results have not yet been obtained. We studied the feasibility of using DNA coding for chimeric rat/human HER2 as a tool to break the unresponsiveness of T
関連コンテンツ
Instructions
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)